R-90118 Senior Director - API Operations (NOT REMOTE - NEW SITE) at Eli Lilly and Company

Chester, Maryland, United States

Apply Now

Not SpecifiedCompensation

Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Healthcare, Pharmaceuticals, BiotechnologyIndustries

Requirements

A Bachelor's degree in a relevant discipline and over 10 years of experience leading operations within the pharmaceutical industry are required. Experience in API manufacturing and Process Safety Management, strong knowledge of cGMPs, proven ability to build relationships, demonstrated success in leading projects, and skills in developing high-performing teams are preferred.

Responsibilities

The Senior Director, Operations will lead manufacturing operations, ensuring capacity, capability, and leadership to meet the site's manufacturing plan, while integrating cross-functional support teams and fostering a strong safety culture. During the startup phase, responsibilities include supporting facility delivery, building the manufacturing organization, developing GMP systems and processes, and shaping site culture. Post-startup, the role involves developing and executing strategic and operational plans, ensuring regulatory compliance, maintaining control systems, monitoring performance, leading continuous improvement initiatives, and developing future leaders.

Skills

API Manufacturing

GMP Systems

Organizational Development

Leadership

Operational Readiness

Process Development

Safety Culture

Strategic Direction

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free